Categories: aggregated

The Trillion-Dollar Question: Why Big Pharma’s Monopoly Fights to Keep Cannabis Illegal?

A recent study published in Health Economics provides a smoking gun that prohibition apologists would prefer you ignore. Researchers found that cannabis legalization reduces prescription drug spending by approximately 6% in small group insurance markets, with the effect growing stronger over time. Translation: when people can legally access cannabis, they spend less money on Big Pharma’s products.

Jason

Share
Published by
Jason

Recent Posts

Twenty Brazilian Cannabis Patient Associations Are Meeting Inside a Free Arts Fair in Fortaleza

Twenty patient associations from across northeastern Brazil are meeting in Fortaleza this month, inside a…

4 hours ago

In 1968 I Faced 70 Years for Giving Away Joints. Fifty-Five Years Later, I Paid $32.16 at the Counter.

In 1968, a few joints I gave away left me facing the possibility of decades…

4 hours ago

A $31.8 Million Reminder That Cannabis Contracts Are Worthless Because Weed is Not Legal Under Federal Law

Here's the part that should worry every operator, investor, and vendor in the industry: this…

4 hours ago

The Cold Stops the Clock: How Fresh Frozen Cannabis Becomes Live Rosin

For one hash maker the clock starts at harvest, and the flower is in the…

2 days ago

Greening Out: Why a Cannabis-Induced Psychedelic State is No Joke

Cannabis can absolutely take you somewhere that looks like a classic psychedelic experience. It just…

2 days ago

Prehistoric High: 25,000-Year-Old Teeth May Hold the Oldest Evidence of Psychoactive Drug Use

Researchers analyzing two ancient skeletons from Indonesia found dramatic dental wear and traces of arecoline,…

3 days ago